|
|
 |
|
Viewing report
|
|
|
|
Chinese Markets for Lymphoma Treatment Drugs
AMID Co., April 2009, Pages: 195
Chinas demand for Lymphoma Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines Chinas economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts through to 2013 and 2018 are presented. Major producers in China are profiled.
Customers who bought this item also bought
Analytical Tool - Lymphoma Therapeutics & Competitive Insights
European Non-Hodgkin's Lymphoma Therapeutics Markets
Stakeholder Opinions: Non-Hodgkins Lymphoma - Is there room to emulate Rituxans success?
Lymphoma - A Therapeutic & Competitive Insight
Stakeholder Opinions: Non-Hodgkins Lymphoma - Immunotherapy Stimulates the Market
Strategic Perspectives: Non-Hodgkin’s Lymphoma A Market Galvanized by the Advent of Innovative Therapies
Triple Progress Analysis: Lymphoma Therapeutics, Protein Kinase Inhibitors & Therapeutic Antibodies
Drugs in the Pipeline--An R&D Analysis
Triple Analysis: The Drug Target Atlas of Apoptopic Drugs in Oncology and Special Focus on Lung Cancer and Melanoma
Triple Analysis: The Drug Target Atlas of Apoptopic Drugs in Oncology and Special Focus on Breast and Prostate Cancer
Pipeline Insight: Cancer Overview - Numerous Diverse Drugs Approaching Fruition
PET/CT and SPECT/CT To Plan and Monitor the Treatment of Cancer
|
|
|
|
